Cleared Traditional

K850339 - SPECIAL PROCEDURES PACK

K850339 is an FDA 510(k) clearance for SPECIAL PROCEDURES PACK, manufactured by Marwood Medical, Inc.. The device is a Class 2 General Hospital device with product code FPA cleared through the Traditional 510(k) pathway after a 43-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1985
Decision
43d
Days
Class 2
Risk

K850339 is an FDA 510(k) clearance for the SPECIAL PROCEDURES PACK. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Marwood Medical, Inc. (Greensboro, US). The FDA issued a Cleared decision on March 12, 1985 after a review of 43 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K850339

510(k) Number K850339 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 28, 1985
Decision Date March 12, 1985
Days to Decision 43 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
86d faster than avg
Panel avg: 129d · This submission: 43d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FPA Device Classification - Class 2, Special Controls

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 1177
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K850339.
CORRECT FLO INTRAVASCULAR ADMINISTRATION SET
K850506 · Biomedical Dynamics, Inc. · Apr 1985
MICRO VOLUME DOUBLE LINE EXTENSION SET
K850061 · Travenol Laboratories, S.A. · Mar 1985
ATLANTIC OPTICAL SYSTEMS OPTIFILTER SYSTEM
K850533 · Atlantic Optical Systems, Inc. · Mar 1985
CRITIKON I.V. ADMINISTRAION SET
K850507 · Critikon Company, LLC · Mar 1985
OMNIMED IV SOLUTION ADMINISTRATION SET
K850112 · Omni Intl., Inc. · Feb 1985
TURN NEEDLE INTRAVENOUS CANNUL, NUB, W/TUBING INTE
K844917 · Turn Needle Intl., Inc. · Feb 1985